Time Course of the Serum Gonadotropin Surge, Inhibins, and Anti-Müllerian Hormone in Normal Newborn Males During the First Month of Life
Overview
Authors
Affiliations
Context: Newborns with ambiguous genitalia or males with nonpalpable gonads usually require an early assessment of the presence and functional state of testicular tissue.
Objective: Our objective was to characterize the precise ontogeny of the serum patterns of gonadotropins, testosterone, anti-Müllerian hormone (AMH), and inhibins in normal newborn boys.
Design: We conducted a cross-sectional and longitudinal study.
Subjects: Serum samples were obtained in 57 boys and 13 girls on d 2 of life. A second sample was obtained on d 7, 10, 15, 20, and 30 (boys) and on d 30 (girls).
Main Outcome Measures: Serum levels of gonadotropins, testosterone, AMH, and inhibins were measured.
Results: In males, LH and FSH were undetectable or very low on d 2. By d 7, LH increased to 3.94 +/- 3.19 IU/liter (mean +/- sd) and FSH to 2.04 +/- 1.67 IU/liter. LH/FSH ratios were 0.40 +/- 0.11 (d 2) and 2.02 +/- 0.20 (d 30). AMH rose from 371 +/- 168 pmol/liter (d 2) to 699 +/- 245 pmol/liter (d 30), and inhibin B rose from 214 +/- 86 ng/liter (d 2) to 361 +/- 93 ng/liter (d 30). The inhibin alpha-subunit precursor (pro-alphaC) remained stable during the first month of life. Testosterone levels were 66 +/- 42 ng/dl (d 2), 82 +/- 24 ng/dl (d 20), and 210 +/- 130 ng/dl (d 30). A sexual dimorphism was observed in AMH and inhibin B (lower in girls on d 2 and 30), in LH/FSH ratio (lower in girls on d 30) and in testosterone (lower in girls on d 30).
Conclusions: Sertoli cell markers AMH and inhibin B are the earliest useful markers indicating the existence of normal testicular tissue.
Current landscape of fertility induction in males with congenital hypogonadotropic hypogonadism.
Dwyer A, McDonald I, Quinton R Ann N Y Acad Sci. 2024; 1540(1):133-146.
PMID: 39190467 PMC: 11471374. DOI: 10.1111/nyas.15214.
The association of infant urinary adrenal steroids with the risk of childhood asthma development.
Turi K, Li Y, Xu Y, Gebretsadik T, Rosas-Salazar C, Wiggins D Ann Allergy Asthma Immunol. 2024; 133(2):159-167.e3.
PMID: 38631429 PMC: 11298305. DOI: 10.1016/j.anai.2024.04.008.
Correa Brito L, Keselman A, Villegas F, Scaglia P, Azcoiti M, Castro S Front Genet. 2024; 15:1354715.
PMID: 38528912 PMC: 10961356. DOI: 10.3389/fgene.2024.1354715.
Anti-Müllerian hormone, testicular descent and cryptorchidism.
Rey R, Grinspon R Front Endocrinol (Lausanne). 2024; 15:1361032.
PMID: 38501100 PMC: 10944898. DOI: 10.3389/fendo.2024.1361032.
Mini-Puberty, Physiological and Disordered: Consequences, and Potential for Therapeutic Replacement.
Rohayem J, Alexander E, Heger S, Nordenstrom A, Howard S Endocr Rev. 2024; 45(4):460-492.
PMID: 38436980 PMC: 11244267. DOI: 10.1210/endrev/bnae003.